-
Symbol
-
XLO on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
4,676,472 shares
-
Security Ownership %
-
6.7%
Frazier Life Sciences Public Fund, L.P. ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)
13 Feb 2026 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,676,472 shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO).
This represents 6.7% ownership of the company.
In their previous filing dated 14 Aug 2025, Frazier Life Sciences Public Fund, L.P. had reported owning 8,141,017 shares, indicating a decrease of +43%.
.